James Giordano, Ph.D. Invited Lectures/Symposia (117) 10. July 2009. Neuroscience, neurotechnology and the philosophy of psychiatry. LeadAmerica Plenary Lecture, Washington, DC. 28. June 2009. Neurobiology, autonomy and agency: Factors in pediatric palliative care. Childrens’ Hospital Foundation Plenary, Minneapolis, MN. 8. May 2009. The paradox of neurotechnology: Assessing the issues at the frontiers of knowledge. Plenary, and chair: Nour Foundation Paradox of Neurotechnology Symposium, Washington, DC. 28. Mar 2009. On the nature of mental disorders and meaning for psychiatry. Invited Lecture: Dept of Psychiatry, University of Leicester, UK. 5. Feb 2009. Neuroethik: Probleme und Fragen zwischen Gehirn, Geist und Gessellschaft. Friedrich Wilhelms Invited Lecture; Rheinische Universität, Bonn. 14. Jan 2009. Education applications from understanding the human mind. Invited plenary. Decade of the Mind-4 Conference, Albuquerque, NM. 13. Jan 2009. Neuroethics: Defining the field at the boundaries and frontiers. Meeting Chair, and plenary speaker. Neuroethics, Legal and Social Issues Meeting; Decade of the Mind-4 Conference, Albuquerque, NM. 6 Dec 2008. Neuroethics: Implications for humanity at the intersection of science, technology, and the mind. Psi Chi Plenary; Dept of Psychology, St. Peter’s College, NJ. 5 Dec 2008. The neuroscience of pain: Basis for an anti-specieist neuroethics? Sigma Xi Plenary; City University of New York, NY 19. Nov 2008. Neuroethics: From theory to practice- implications for education and curriculum. Invited Lecture. Villanova University, Philadelphia, PA. 12 Sept 2008. Neurobiology of neonatal and pediatric pain: Ontogeny and the ethics of agency. Washington Pediatric Hospice Assn, Invited Plenary, Washington, DC 6. Sept 2008. Core philosophy of pain medicine: From neuroscience to neuroethics of pain. Plenary Lecture: PainWeek 2008, Las Vegas NV. 5. Sept 2008. Neural mechanisms of pain and analgesia: From periphery to brain-mind- A role for neruotechonlogy. Plenary lecture: PainWeek 2008, Las Vegas NV. 4. Sept 2008. On the ethical duty to relieve pain. Plenary lecture: PainWeek 2008, Las Vegas NV 30 July 2008. Pain and pain care in pediatric patients: Implications for autonomy, agency and the nature of self. Nemours Childrens’ Hospital, Wilmington DE 22. March 2008. Traumatic brain injury: A putative neuropsychiatric spectrum disorder? Implications for research and ethical obligations of care. NY Academy of Traumatic Brain Injury, Invited Plenary, NYU Hospital, NY. 9. March 2008. Substance abuse: Potential mechanisms of a spectrum disorder. Oxford Roundtable on Science and Healthcare. Lincoln College, University of Oxford, UK 22. October 2007. Placebo effects and responses: neurobiological basis, practical and ethical issues in the spirit of cura personalis. Invited lecture: Dept. of Physiology and Biophysics, Georgetown University Seminar Series, Washington, DC 21. October 2007. Neuroethics: A bigger picture – bottom-up and top-down considerations. Invited panel lecture: American Society of Bioethics and Humanities, Washington, DC 19. September 2007. Body, brain-mind, and spirit: consilient values and virtues in Jesuit education. Invited speaker: Michelmas Convocation, St. Peter’s College, NJ 5. September 2007. From neuroscience to a neuroethics of pain: Implications for constituent disciplines of pain medicine. Invited plenary: American Society of Pain Educators, Las Vegas, NV. 23. June, 2007. Philosophy and ethics of pain management: Concepts, and practical applications toward a unity of brain, mind, meaning and morality in healing. Invited lecture: American Society of Interventional Pain Physicians’ Capitol Hill Meeting, Washington, DC. 11. June 2007 Suffering, the self, and the clinical encounter. George Washington University Hospital, and School of Medicine Grand Rounds, Washington, DC 10. May 2007 Ethical imperatives and obligations for research in CAM: Can a core philosophical basis enable a truly integrative medicine? Plenary: International Congress on Complementary Medicine Research, Munich, GER 7. May 2007 Moral agency in pain medicine. Invited Universum Lecture. Dept of Moral Theology and Philosophy, Universitaet Bonn, Bonn, GER 21 April 2007 At the interface of brain, mind and machine: Neuroethics of neurobiotechnology. 14. April 2007 Understanding a neuroscience of suffering to derive an agent-based ethics of medicine. Plenary, Delaware Medical Society Annual Meeting, Wilmington DE. 2. April 2007 New vistas in brain, mind, and healing research: Toward a translational effort of 15. March 2007 Science and spirituality: Natural philosophical foundations, 4. December 2006 Does the neuroscience of pain ground a neuroethics of pain medicine? 20. November 2006 Clinical ethics in medicine: Historical perspective, potential and problems for the present and future. Cornell University Symposium on History in Medicine. Washington, DC. 7. September 2006 Beyond the analgesic ladder: Ethical and practical issues in analgesic pharmacotherapeutics and drug development. Plenary Lecture: American Academy of Pain Management Clinical Meeting, Orlando FL. 29. August 2006 Ethical implications for and in infrared imaging biotechnology research and practice. International Biomedical Engineering Society Conference, New York, NY 7. August 2006 Profession, moral obligation and the ethical practice of pain medicine. Plenary lecture, American Society of Interventional Pain Physicians, St. Louis, MO 10 July 2006 Regrounding medicine in humanity amidst technocracy and cultural pluralism: On the need for a philosophy of medicine. Invited lecture; Roundtable in Arts and Sciences, Harris Manchester College, University of Oxford, Oxford, UK 25. June 2006 Placebo and nocebo: Science, evidence and ethics in research and practice. Manchikanti Distinguished Lecture, American Board of Pain Medicine Congressional Meeting, Washington, D.C. 25. May 2006 The problem of pain, and the process and purpose of policy. Invited Lecture: Delaware Medical Society, Wilmington, DE 21. April 2006 From a neuroscience to a neurophilosophy of pain: Implications for ethics in research and practice of pain medicine. Colorado Consortium of Professional Psychology, Colorado Springs, CO 16. March 2006 A right and good healing: Philosophical basis and ethical obligations inherent to medical integration. Plenary Lecture: ACC-Research Advisory Council Conference, Tysons Corner, VA 3. March 2006 Virtue as a bridge to facilitate integration of complementary and mainstream medicine. Association for Professional and Practical Ethics, Jacksonville, FL. 18 February 2006 The neurobiology and neurophilosophy of mind-body interactions: Implications for medical practice and bioethics. CG Jung Center, Houston, TX 17 February 2006 Can the neurobiology of pain contribute to both the neurophilosophy of mind and an ethic of care? University of Texas Health Sciences Center, Houston, TX 16 February 2006 Mechanisms and ethical use of acupuncture as co-opted technique or therapeutic system within an integrated medical model. TIRR, Houston, TX. 28 October 2005 Healing what cannot be cured: The legacy of Albert Schweitzer’s “Reverence for Life” in a contemporary philosophy of medicine. Tenth Annual Albert Schweitzer Memorial Symposium, Albert Schweitzer Center, Quinnipiac University, CT. 7 October 2005 Complementary, but not alternative to medicine: The importance of a core-philosophy and virtue-based ethics to enhance cultural competence and integration of CAM and mainstream medicine. Neiswanger Institute Conference on Medical Education and Cultural Competence, Loyola University, Chicago, IL. 24 September 2005 Neurophilosophy of maldynic pain: Disease, illness and ethical obligations to treatment. Plenary Lecture: American Academy of Pain Management Clinical Meeting, San Diego, CA 9 September 2005 Ethics of pain research and medicine: Neuroscience and the basis of therapeutic and moral agency. Invited Plenary Lecture: American Society of Pain Educators National Forum, Las Vegas, NV 6-7 August 2005 Neuroanatomy and pathophysiology of pain: Toward a reconciliation of disease process and illness phenomenon. Invited plenary lecture: American Society of Interventional Pain Physicians. St Louis, MO 29 June, 2005 Autonomic substrates of neuropathic pain syndromes: Ethical and pragmatic issues in quantification of qualitative variables. Plenary Lecture: American Academy of Thermology, Baton Rouge, LA. 19 March 2005 Ethical obligations defining the need for evidence-based practice of complementary therapeutics an integrative medical model. Research Advisory Committee/ACC, Las Vegas, NV. 9 September, 2004 The role of serotonin 5-HT3 receptors in pain and anti-nociception: A mechanism for channelopathic maldynia and its cognitive effects. American Academy of Pain Management Clinical Meeting, San Antonio, TX 8 August, 2004 Nociceptive and neuropathic pain: anatomy, physiology, iatrogenic factors dictating ethical care. American Society of Interventional Pain Physicians, St. Louis, MO 19 January, 2004 Anatomic, chemical and molecular basis of maldynic pain: physiologic and cognitive neuroscientific relevance to a neurophilosophy of pain. American Academy of Pain Medicine Invited Lecture, Newport, CA 10 September, 2003 Neural mechanisms of pain and analgesia: role of neurologic substrates in determining patient responses: Ethical responsibilities. American Society of Interventional Pain Physicians, Alexandria, VA. 6 September, 2003 Neurobiology of nociception and pain modulation: Novel roles for serotonergic and nitric oxidergic substrates in clinical syndromes. American Academy of Pain Management Clinical Meeting, Denver, CO. 20 August 2003 Phytomedicinal and nutriceutical approaches to managing chronic pain in the sports’ medical setting: Evidence-based approaches and ethical use. Baylor Sports Medicine Institute, Houston, TX. 8 September 2002 Neurochemical basis of type II and type III pain: implications for ethical pharmacotherapeutics. American Academy of Pain Management Clinical Meeting, Reno, NV 19 February, 2002 Utility of sertraline in reducing chronic pain and specific neuroendocrine parameters of fibromylagia. Pfizer Grand Rounds Series Lecture, College Station, TX. 22. January, 2002 Role of serotonin receptors and reuptake sites in mediating the symptomatic constellation in fibromyalgic patients. Pfizer Grand Rounds Series Lecture, Texas Methodist Hospital, Houston, TX 8 January 2002 Forensic neurology in aviation accident reconstruction. FAA Safety Lecture Series, Houston, TX. 1 November 2001 Integrative pain management: A role for complementary and alternative therapeutics, and ethical parameters. Rice University, Houston, TX. 26 October 2001 Pharmacodynamic and kinetic parameters of celecoxib and rofecoxib suggest distinct utility in the treatment of uncomplicated myofascial pain. Texas Medical Association Grand Rounds Meeting, Houston, TX. 23 August 2001 COX-II inhibitors in the treatment of primary myofascial pain syndrome: beyond the RCT. Texas Methodist Hospital Grand Rounds, Houston, TX 19 April 2001 Neuropharmacology of serotonin reuptake sites in brain and spinal cord: implications for pragmatically appropriate and ethically sound use of specific SSRIs for pain based upon pharmacokinetic and dynamic effects. Memorial Hermann Hospital Grand Rounds Lecture, Houston, TX 24 March 2001 The serotonergic system in chronic pain and depression: chemical co-morbidity may indicate pharmacotherapeutic specificity. Pfizer Grand Rounds Series, Methodist Hospital, Houston, TX 13 March 2001 Serotonin receptors in maldynic pain and depressive illness: targets for drug therapy. Harris County Medical Association Meeting, Houston, TX 20 January 2001 Use of biochemical markers in the pharmacotherapeutics of the depressed chronic pain patient. SE Texas Medical Association Meeting, Beaumont, TX 14 June 2000 Neurophysiology of stress factors in high performance aircraft flight. Center for Aviation Safety Education, Embry-Riddle Aeronautical University, Prescott, AZ 8 June 2000 Pain medicine: from research to practice: Ethical implications. Texas Healthcare Network Lecture Series, Houston, TX 9 March 2000 Serotonin receptors in the mediation of migraine headache and atypical cephalalgia. Merck Sharpe-Dohme Grand Rounds Lecture Series, Austin, TX 9 June, 1999 Stress effects on human factors contributory to industrial accidents and pain: Ethical responsibilities for occupational medicine. Texas Chemical Society Conference, Conroe, TX. 19 May, 1999 New developments in psychopharmacology: The ethics of psychogenetics. S.E. Texas Psychological Association, Beaumont, TX. 22 January, 1999 Chronic pain: advances in research, diagnosis and treatment. National Academy of Continuing Education, Jacksonville, FL. 21 January, 1999 Stress factors affecting accident susceptibility and resultant pain. American Society of Safety Engineers Regional Conference, Beaumont, TX. 8 November, 1998 Behavioral medical issues in chronic pain: Ethical issues in pain research and therapy. Grand Rounds, St. Elizabeth’s Hospital, Beaumont, TX. 2 November, 1998 Medical certification for aviators: disease, illness and truth-telling in practice. Greater Houston Association of Flight Instructors’ Conference, Houston, TX. 10 September, 1998 Effective management of human factors dynamics in aviation safety programs. Houston FSDO Aviation Safety Training Course, Houston, TX. 9 July, 1998 Sexual Dysfunction: Diagnoses, pathology and therapy in chronic pain patients. Texas Psychological Association, Beaumont, TX. 4 July, 1998 Human factors in pilot performance. Galveston Area Aviation Society, Dept. Aviation Medicine UTMB, Galveston, TX. 11 February, 1998 Identifying and managing aviation stress factors. S.E. Texas Pilots’ Assn., Beaumont, TX. 14 January, 1998 Personality factors in aviator performance. Beaumont Flight Safety Meeting, Beaumont, TX. 17 December, 1997 Ergonomics and bioengineering in general aviation. S.E. Texas Pilots’ Assn., Houston, TX. 15 November, 1997 Factors in aircraft crash survival. Houston Area Flight Standards and Safety Meeting. 17 October, 1997 Geriatric Pain Management: Teaching old dogma new tricks. Texas Statewide Consortium on Gerontology, Beaumont, TX. 15 August, 1997 The many faces of pain: new vistas in bioethical pain management. Ward Symposium, John Gray Center, Beaumont, TX. 1 February, 1997 Donepezil: a novel agent in treating Alzheimer’s dementia. Alzheimer’s Disease Foundation, Austin, TX. 5 February, 1997 Novel approaches to analgesic pharmacotherapy: Ethical and medico-legal parameters in clinical practice. St. Elizabeth Conference in Advances in Healthcare, Beaumont, TX. 19 February, 1997 Multidisciplinary approaches to chronic pain management. Department of Medicine and Surgery, Jennie Sealy Hospital, UTMB, Galveston, TX. 20 February, 1997 Pathophysiology of Alzheimer’s dementia: utility of donepezil pharmacotherapy. Conference of Beaumont Primary Care Providers/Physicians, Beaumont, TX. 16 November, 1996 Environmental effects on neurogenesis: Implications for nature, nurture and neurology. Texas Perinatal Assn. Annual Conference, Dallas, TX. 26 October, 1996 Myofascial Pain Syndrome: Serotonergic substrates as targets for therapy. S.F. Austin State University Clinical Care Conference, Nacogdoches, TX. 16 July, 1996 Biopsychology of stress responses: practical and bioethical implications for occupational medicine. Integrated Health Care Dept. , E.I. DuPont Co., Beaumont, TX. 4 December, 1995 Putative role of serotonin 5-HT3 receptors in pain and analgesia. Pain Study Section, Roche Biosciences, Palo Alto, CA. 14 October – 18 November, 1995 Exercise Physiology: A role in conservative, chronic pain management. Invited Lecture Series: Pinnacle Health Care, Havelock, NC. 12 October, 1994 Biomechanical implications of Aviator Back Syndrome relevant to Gz-axis impact-acceleration injury susceptibility and pain. Safety and Flight Equipment Conference, Reno, NV. 30 April, 1992 Effects of unusual movement, disorientation, pain and stress on aviator physiology and performance. FAA Medical Safety Seminar, Des Moines, IA. 21 April, 1992 The spinal and peripheral 5-HT receptor system and inflammatory pain: Ontogeny and functional mechanisms. Dept. of Neuroscience, University of Minnesota, Minneapolis, MN. 23 March, 1992 5-HT receptor-mediation of pain and analgesia: new vistas and pharmacologic implications. Depts. of Biophysics and Neuroscience, Allegheny General Hospital Center, Pittsburgh, PA. 12 March, 1992 Central nervous system mechanisms of vertigo and disorientation in aviators: role of 5-HT and 5-HT receptors. FAA Midwest Chapter Seminar, Cedar Rapids, IA. 16 February, 1992 Central and peripheral nervous systems as pharmacological targets for stress and pain management. U.S. Navy Fleet Hospital, Des Moines, IA. 18 November, 1991 Assessment and treatment of pain and stress in research animals: Practical and ethical concerns. Depts. of Pharmacology and Psychiatry, Allegheny-Singer Research Institute, Pittsburgh, PA. 9 September, 1991 Advances in research and therapy of Parkinson’s disease: Confronting bioethical issues in fetal tissue utilization. Iowa Parkinson’s Disease Society, Des Moines, IA. 29 April, 1991 Pharmacologic substrates of pain and pain modulation. Mind and Medicine Annual Lecture Series. Dept. of Pharmacology and Physiology University of Osteopathic Medicine and Health Sciences, Des Moines, IA. 5 March, 1991 Azapirone 5-HT1A agonist effects on CNS and neuroendocrine substrates of analgesia. Mead-Johnson Invited Lecture, Des Moines, IA. 25 February, 1991 Putative mechanisms of azapirone-induced analgesia. Invited Lecture/Grand Rounds, Allegheny-Singer Research Institute, Pittsburgh, PA. 20 November, 1990 Serotonin 5-HT1A and 5-HT3 receptor mediation of nociception. Sigma Xi Distinguished lecture, Iowa State University College of Veterinary Medicine, Ames, IA. 12 November, 1990 Interaction of serotonergic and neuroendocrine systems in pain modulation. Sandoz Colloquium on Somatostatin and Pain, New York, NY. 10 September, 1990 Physio-pharmacology of stress and pain: A shared system of mind and body?. Invited lecture: University of Osteopathic Medicine and Health Science, Des Moines, IA. 20 September, 1990 Novel therapeutic approaches against neurodegenerative disorders: Practicality and ethics. Iowa Parkinson’s Disease Society, Des Moines, IA. 18 August, 1989 Anatomy and pharmacology of antinociceptive systems in neonates: Developmental effects of pharmacotherapy. Grand Rounds Neonatal Intensive Care Unit Iowa Methodist Medical Center, Des Moines, IA. 23 May, 1989 Analgesic systems in the newborn: Practical and ethical implications for pharmacotherapeutics. Iowa Methodist Medical Center: Conference for Pediatric and Neonatal Nursing, Iowa City, IA. 19 April, 1989 Cellular and molecular pharmacology of novel anxiolytic and antidepressant agents. Polk County Mental Health Foundation, Des Moines, IA. 14 April, 1989 Patterns of analgesia produced by the novel anxiolytic buspirone: Implications for clinical utility. Interdisciplinary Conference on Rehabilitative Neurology, Iowa Methodist Foundation, Des Moines, IA. 3 April, 1989 Neuromodulation of spinal and supraspinal analgesic systems in the neonatal rat. Depts. of Physiology and Pharmacology, Iowa State University College of Veterinary Medicine, Ames, IA. 14 September, 1988 Advances in pharmacotherapeutics of opioid abuse. Interdisciplinary Narcotic Control Conference Iowa Governor’s Alliance on Substance Abuse, Des Moines, IA. 9 September, 1988 Pharmacologic mechanisms of narcotic dependence: Perspectives on novel treatment approaches in fetal addictive syndromes. Grand Rounds, Dept. of Pediatrics Blank Hospital, Iowa Methodist Medical Center, Des Moines, IA. 21 August, 1988 Stress-, and exercise-induced alterations in opioid neurochemistry. 1st Symposium on Fitness Medicine, Kansas City, MO. 18 August, 1988 Pharmacologic and genetic mechanisms of substance abuse. Drug Abuse Center, Powell Clinic, Iowa Methodist Medical Center, Des Moines, IA. 10 May, 1988 Pharmacology and development of bulbospinal systems in opiate anti-nociception. Dept. of Pharmacology, Philadelphia College of Pharmacy and Health Sciences, Philadelphia, PA. 1 February, 1988 Changing neuropharmacologic patterns of opioid analgesia in neonatal rats. Depts. of Psychology and Anatomy, University of Rochester, Rochester, NY. 18 October, 1987 Pharmacologic substrates of stimulus-specificity in spinal and supraspinal opioid analgesia. Dept. of Clinical Neuropharmacology, Max Planck Institut fur Psychiatrie, Munich, Germany. |
James Giordano, Ph.D. © 2005, All rights reserved.